Parkes Weber Syndrome: Clinical Manifestations, Diagnostic Challenges, and Contemporary Management Strategies
Main Article Content
Abstract
Parkes Weber syndrome (PWS) is a rare congenital vascular anomaly characterized by a triad of capillary, venous, and lymphatic malformations associated with high-flow arteriovenous fistulas. This syndrome, often presenting with limb hypertrophy and cutaneous vascular lesions, poses significant diagnostic and therapeutic challenges due to its overlap with similar vascular syndromes such as Klippel-Trénaunay syndrome. Advances in imaging modalities, including Doppler ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA), have refined the diagnostic accuracy, enabling early detection and detailed vascular mapping. Current management strategies emphasize multidisciplinary approaches, integrating interventional radiology, surgical techniques, and symptomatic treatments. Despite these advancements, the natural history of PWS underscores a significant risk of complications, including chronic pain, ulceration, and potential cardiac overload from high-output heart failure. This review aims to provide a comprehensive overview of the clinical features, diagnostic processes, and evolving therapeutic modalities for Parkes Weber syndrome, highlighting recent innovations and unmet needs in the care of affected individuals.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Classification. International Society for the Study of Vascular Anomalies. [cited 2025 Jan]
Available at: https://www.issva.org/classification
II. Dekeuleneer V, Seront E, van Damme A, Boon LM, Vikkula M. Theranostic advances in vascular malformations. J Invest Dermatol. 2020;140(4):756–763.
III. Queisser A, Seront E, Boon LM, Vikkula M. Genetic basis and therapies for vascular anomalies. Circ Res. 2021;129(1):155–173.
IV. Banzic I, Brankovic M, Maksimović Z, Davidović L, Marković M, Rančić Z. Parkes Weber syndrome-Diagnostic and management paradigms: a systematic review. Phlebology. 2017;32(6):371–383.
V. Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat. 2008;29(7):959–965.
VI. Boccara O, Eyries M, Pannier S, Ariche-Maman S, Hadj-Rabia S, Coulet F. Parkes-Weber syndrome related to RASA1 mosaic mutation. Clin Genet. 2021;99(2):330–331.
VII. Flores Daboub JA, Grimmer JF, Frigerio A, et al. Parkes Weber syndrome associated with two somatic pathogenic variants in RASA1. Cold Spring Harb Mol Case Stud. 2020;6(4):a005256.
VIII. Diociaiuti A, Paolantonio G, Zama M, et al. Vascular birthmarks as a clue for complex and syndromic vascular anomalies. Front Pediatr. 2021;9:730393.
IX. Keppler-Noreuil KM, Rios JJ, Parker VER, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287–295.
X. Tuleja A, Bernhard SM, Hamvas G, et al. Clinical phenotype of adolescent and adult patients with extracranial vascular malformation. J Vasc Surg Venous Lymphat Disord. 2023;11(23):1034–1044.e3.
XI. Froyen G, Geerdens E, Berden S, Cruys B, Maes B. Diagnostic validation of a comprehensive targeted panel for broad mutational and biomarker analysis in solid tumors. Cancers. 2022;14(10):2457.
XII. Vuillemin N, Bernhard S, Haine A, et al. Capillary-venule malformation is a microfistulous variant of arteriovenous malformation. J Vasc Surg Venous Lymphat Disord. 2021;9(1):220–225.
XIII. Bernhard SM, Tuleja A, Laine JE, et al. Clinical presentation of simple and combined or syndromic arteriovenous malformations. J Vasc Surg Venous Lymphat Disord. 2022;10(3):705–712.
XIV. Bernhard SM, Döring Y, Vassella E, Amstutz U, Zweier C, Rössler J, et al. Oncogene targeted next-generation-sequencing in extra-cranial arteriovenous malformations. 2023
XV. Cohen MM. Klippel-Trenaunay syndrome. Am J Med Gen. 2000;93(3):171–175.